People with sickle cell disease experience excruciating pain crises, tissue and organ damage, and shortened life expectancy. The lab of Stuart Orkin made crucial discoveries that, in the hands of CRISPR Therapeutics and Vertex Pharmaceuticals, became an FDA-approved gene therapy that is making a monumental impact on patients with sickle cell disease.
Related Posts
Thinking of Stopping Blood Pressure Meds? Here's What You Need to Know
June 29, 2026
Before you stop taking blood pressure medication, discover expert advice on safe practices, lifestyle changes, and essential questions for your doctor.
Thriving at 74: The Inspiring Journey of Living with HIV for 30 Years
June 29, 2026
Meet Barbara Roberts, who has been living with HIV for over 30 years, now thriving at 74 thanks to new treatment advancements. Discover her incredible story.
FAA Embraces AI to Transform Air Traffic Control Safety
June 22, 2026
Explore how the FAA's partnership with AI firms, like Palantir, aims to enhance air traffic control safety and reduce runway incidents.
Unveiling Hidden Muscle Fat: A Silent Threat to Your Heart Health
June 22, 2026
Discover how hidden muscle fat may raise your risk of heart disease and metabolic disorders, and what you can do to combat it.